Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) will host a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference.

The event is scheduled for June 12, 2024, at 4:00 p.m. ET.

A live webcast will be accessible via the company's website on the 'Events and Presentations' page under the 'Investors and Media' section.

A replay of the webcast will be available for 90 days post-event.

Positive

• Opportunity for increased investor visibility and interest.
• Potential for new partnerships or collaborations announced during the event.
• Accessible webcast increases outreach and engagement.

Negative

• Lack of concrete news or updates that could directly impact stock price.
• No financial or clinical data disclosed in the announcement.
• immediate business impact from this type of event.

WALTHAM, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024, at 4:00 p.m. ET.

The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact:
Meredith Kaya 
meredith.kaya@apellis.com
617.599.8178

FAQ

When is Apellis Pharmaceuticals' fireside chat at the Goldman Sachs Healthcare Conference?

The fireside chat is scheduled for June 12, 2024, at 4:00 p.m. ET.

How can I access the live webcast of Apellis Pharmaceuticals' fireside chat?

The live webcast will be available on the 'Events and Presentations' page under the 'Investors and Media' section of Apellis Pharmaceuticals' website.

Will there be a replay available for Apellis Pharmaceuticals' fireside chat at the Goldman Sachs Healthcare Conference?

Yes, a replay of the webcast will be available for approximately 90 days following the event.

What is the significance of Apellis Pharmaceuticals' participation in the Goldman Sachs Healthcare Conference?

Participation in the conference can increase investor visibility and potentially lead to new partnerships or collaborations.